Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and Interventions.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Atrial Fibrillation

• Publication date

  2013-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.4022/jafib.869PMID 28496876PMCID PMC5153234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors of late recurrence of atrial fibrillation after catheter ablation.

  2013cited by this paper
• Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target

  2012cited by this paper
• Alteration of Purinergic Neurotransmission in Isolated Atria of Streptozotocin-induced Diabetic Rats

  2012cited by this paper
• Insulin resistance and atrial fibrillation (from the Framingham Heart Study).

  2012cited by this paper
• Preventing β-Cell Loss and Diabetes With Calcium Channel Blockers

  2012cited by this paper
• Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study.

  2012cited by this paper
• Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion.

  2012cited by this paper
• Association Between Left Atrial Size and Measures of Adiposity Among Normal Adolescent Boys

  2012cited by this paper
• The ECG Vertigo in Diabetes and Cardiac Autonomic Neuropathy

  2011cited by this paper
• Serum resistin level: as a predictor of atrial fibrillation after coronary artery bypass graft surgery

  2011cited by this paper
• Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study

  2011cited by this paper
• Effect of dietary fish oil on atrial fibrillation after cardiac surgery.

  2011cited by this paper
• Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

  2011cited by this paper
• n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion: A Prospective, Randomized Study

  2011cited by this paper
• Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus.

  2011cited by this paper
• Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation.

  2011cited by this paper
• The vanishing story of angiotensin II receptor blockers in the treatment of atrial fibrillation.

  2011cited by this paper
• The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation

  2011cited by this paper
• Effect of bariatric surgery on cardiovascular risk profile.

  2011cited by this paper
• Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery.

  2011cited by this paper
• Pericardial fat is associated with atrial fibrillation severity and ablation outcome.

  2011cited by this paper
• Total and Interatrial Epicardial Adipose Tissues Are Independently Associated With Left Atrial Remodeling in Patients With Atrial Fibrillation

  2011cited by this paper
• Long-term effects of intensive glucose lowering on cardiovascular outcomes.

  2011cited by this paper
• Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose.

  2010cited by this paper
• The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females.

  2010cited by this paper
• Pericardial Fat Is Associated With Prevalent Atrial Fibrillation: The Framingham Heart Study

  2010cited by this paper
• Pathophysiology of the proatherothrombotic state in the metabolic syndrome.

  2010cited by this paper
• Left Atrial Epicardial Adiposity and Atrial Fibrillation

  2010cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• YKL-40: a new biomarker in cardiovascular disease?

  2010cited by this paper
• Improving stroke risk stratification in atrial fibrillation.

  2010cited by this paper
• Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.

  2010cited by this paper
• Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation

  2010cited by this paper
• Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation

  2010cited by this paper
• Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.

  2010cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study).

  2010cited by this paper
• Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes.

  2010cited by this paper
• New oral anticoagulant drugs in cardiovascular disease

  2010cited by this paper
• Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population.

  2010cited by this paper
• Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.

  2010cited by this paper
• Pericardial fat is independently associated with human atrial fibrillation.

  2010cited by this paper
• The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence

  2010cited by this paper
• Plasma YKL-40, a new biomarker for atrial fibrillation?

  2009cited by this paper
• Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy

  2009cited by this paper
• Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation.

  2009cited by this paper
• The clinical implications of blood adiponectin in cardiometabolic disorders.

  2009cited by this paper
• Body mass index and risk of left atrial thrombus in patients with atrial fibrillation.

  2009cited by this paper
• Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery.

  2009cited by this paper
• Electrophysiologic Characteristics of Complex Fractionated Atrial Electrograms in Patients with Atrial Fibrillation

  2009cited by this paper
• The metabolic syndrome as a risk factor for venous and arterial thrombosis.

  2009cited by this paper
• Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.

  2009cited by this paper
• The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study.

  2009cited by this paper
• Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart.

  2009cited by this paper
• Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men.

  2009cited by this paper
• Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation

  2009cited by this paper
• Relationship Between Adiponectin and Left Atrium Size in Uncomplicated Obese Patients: Adiponectin, a Link Between Fat and Heart

  2009cited by this paper
• Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism.

  2008cited by this paper
• Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

  2008cited by this paper
• Atrial fibrillation and obesity--results of a meta-analysis.

  2008cited by this paper
• Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.

  2008cited by this paper
• Atrial fibrillation susceptibility in metabolic syndrome: simply the sum of its parts?

  2008cited by this paper
• Major weight loss prevents long-term left atrial enlargement in patients with morbid and extreme obesity.

  2008cited by this paper
• Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data

  2008cited by this paper
• Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study

  2008cited by this paper
• Epicardial Adipose Tissue Adiponectin Expression is Related to Intracoronary Adiponectin Levels

  2008cited by this paper
• Circulating adiponectin levels in patients with atrial fibrillation.

  2008cited by this paper
• Inflammation and atrial fibrillation: cause or effect?

  2008cited by this paper
• High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome.

  2007cited by this paper
• Independent predictors of stroke in patients with atrial fibrillation

  2007cited by this paper
• Do cardiac neuropeptides play a role in the occurrence of atrial fibrillation after coronary bypass surgery?

  2007cited by this paper
• Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.

  2007cited by this paper
• Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus—single center experience

  2007cited by this paper
• Impact of the Metabolic Syndrome on Atrial Size in Patients With New-Onset Atrial Fibrillation

  2007cited by this paper
• The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.

  2007cited by this paper
• Obesity and thrombosis.

  2007cited by this paper
• Obesity and Metabolic Syndrome Are Independent Risk Factors for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery

  2007cited by this paper
• Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes.

  2007cited by this paper
• Electrical cardioversion for persistent or chronic atrial fibrillation: outcome and clinical factors predicting short and long term success rate.

  2006cited by this paper
• The assessment of autonomic function in chronic atrial fibrillation: description of a non-invasive technique based on circadian rhythm of atrioventricular nodal functional refractory periods.

  2006cited by this paper
• What are Arrhythmogenic Substrates in Diabetic Rat Atria?

  2006cited by this paper
• Meta-analysis of the effect of thiazolidinediones on serum C-reactive protein levels.

  2006cited by this paper
• Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors

  2006cited by this paper
• Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis.

  2006cited by this paper
• Adiponectin Acts as an Endogenous Antithrombotic Factor

  2006cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes.

  2005cited by this paper
• Obesity and Risk of New-Onset Atrial Fibrillation After Cardiac Surgery

  2005cited by this paper
• n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

  2005cited by this paper
• Atrial Fibrillation: Basic Mechanisms, Remodeling and Triggers

  2005cited by this paper
• Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

  2005cited by this paper
• Vascular risk factors and diabetic neuropathy.

  2005cited by this paper
• A short course of oral amiodarone improves sinus rhythm maintenance post-cardioversion for atrial fibrillation

  2004cited by this paper
• Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction.

  2004cited by this paper
• Association of Atrial Fibrillation and Obstructive Sleep Apnea

  2004cited by this paper
• Pleiotropic effects of thiazolidinediones: Taking a look beyond antidiabetic activity

  2004cited by this paper
• Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status.

  2004cited by this paper
• Obesity and the risk of new-onset atrial fibrillation.

  2004cited by this paper
• Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators

  2003cited by this paper
• Inflammation as a Risk Factor for Atrial Fibrillation

  2003cited by this paper

• Cardiomyocyte electrophysiology and its modulation: current views and future prospects

  2023cites this paper
• Pathological role of advanced glycation end products (AGEs) and their receptor axis in atrial fibrillation.

  2019cites this paper
• Atrial fibrillation risk factor management with a plant‐based diet: A review

  2019cites this paper
• Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.

  2018cites this paper
• A new insight into the molecular mechanism of thiazolidinediones in atrial fibrillation

  2018cites this paper
• Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose–response meta-analysis of prospective studies

  2017cites this paper
• Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

  2017cites this paper
• Prospective assessment of cytokine IL-15 activity in patients with refractory atrial fibrillation episodes.

  2015cites this paper
• Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis.

  2015cites this paper
• Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study

  2015cites this paper